AAAAAA

   
Results: 1-12 |
Results: 12
Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer
Authors: Rubin, BP Skarin, AT Pisick, E Rizk, M Salgia, R
Citation: Bp. Rubin et al., Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer, EUR J CAN P, 10(1), 2001, pp. 77-82
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
Authors: Herbst, RS Lynch, C Vasconcelles, M Teicher, BA Strauss, G Elias, A Anderson, I Zacarola, P Dang, NH Leong, T Salgia, R Skarin, AT
Citation: Rs. Herbst et al., Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial, CANC CHEMOT, 48(2), 2001, pp. 151-159
Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer
Authors: Salgia, R Harpole, D Herndon, JE Pisick, E Elias, A Skarin, AT
Citation: R. Salgia et al., Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer, ANTICANC R, 21(2B), 2001, pp. 1241-1246
Lung cancer in patients under age 40
Authors: Skarin, AT Herbst, RS Leong, TL Bailey, A Sugarbaker, D
Citation: At. Skarin et al., Lung cancer in patients under age 40, LUNG CANC, 32(3), 2001, pp. 255-264
Editor's note: PNET versus PPNET
Authors: Skarin, AT
Citation: At. Skarin, Editor's note: PNET versus PPNET, J CL ONCOL, 19(7), 2000, pp. 2101-2101
Malignant pleural mesothelioma
Authors: Ho, L Sugarbaker, DJ Skarin, AT
Citation: L. Ho et al., Malignant pleural mesothelioma, CANC TREAT, 2000, pp. 327-373
Molecular and cellular biological abnormalities in lung cancer and the potential for novel therapeutics
Authors: Salgia, R Skarin, AT
Citation: R. Salgia et At. Skarin, Molecular and cellular biological abnormalities in lung cancer and the potential for novel therapeutics, LUNG BIOL H, 140, 2000, pp. 3-25
Chemotherapy of advanced non-small-cell lung cancer
Authors: Dang, NH Herbst, RS Skarin, AT
Citation: Nh. Dang et al., Chemotherapy of advanced non-small-cell lung cancer, LUNG BIOL H, 140, 2000, pp. 235-279
Multimodality treatment of lung cancer - Preface
Authors: Skarin, AT
Citation: At. Skarin, Multimodality treatment of lung cancer - Preface, LUNG BIOL H, 140, 2000, pp. V-IX
Gynecomastia in a patient with lung cancer
Authors: Liu, G Darling, MLR Chan, J Jaklitsch, MT Skarin, AT
Citation: G. Liu et al., Gynecomastia in a patient with lung cancer, J CL ONCOL, 17(6), 1999, pp. 1956-1957
Dose-intensive therapy for limited-stage small-cell lung cancer: Long-termoutcome
Authors: Elias, A Ibrahim, J Skarin, AT Wheeler, C McCauley, M Ayash, L Richardson, P Schnipper, L Antman, KH Frei, E
Citation: A. Elias et al., Dose-intensive therapy for limited-stage small-cell lung cancer: Long-termoutcome, J CL ONCOL, 17(4), 1999, pp. 1175-1184
Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma
Authors: Salgia, R Hedges, TR Rizk, M Reimer, RH Skarin, AT
Citation: R. Salgia et al., Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma, LUNG CANC, 22(2), 1998, pp. 149-152
Risultati: 1-12 |